Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026SEONG, Yeon-Sun; MIN, Changhee; LI, Luowei et al.Cancer research (Baltimore). 2003, Vol 63, Num 21, pp 7384-7391, issn 0008-5472, 8 p.Article

AZ703, an lmidazo[1,2-a]pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9DONGPO CAI; BYTH, Kate F; SHAPIRO, Geoffrey I et al.Cancer research (Baltimore). 2006, Vol 66, Num 1, pp 435-444, issn 0008-5472, 10 p.Article

Cyclin-dependent kinase pathways as targets for cancer treatmentSHAPIRO, Geoffrey I.Journal of clinical oncology. 2006, Vol 24, Num 11, pp 1770-1783, issn 0732-183X, 14 p.Article

CDK Inhibitors : Cell Cycle Regulators and BeyondBESSON, Arnaud; DOWDY, Steven F; ROBERTS, James M et al.Developmental cell. 2008, Vol 14, Num 2, pp 159-169, issn 1534-5807, 11 p.Article

Retinal and peripheral nerve toxicity induced by the administration of a pan-cyclin dependent kinase (cdk) inhibitor in miceILLANES, Oscar; ANDERSON, Scott; NIESMAN, Michael et al.Toxicologic pathology. 2006, Vol 34, Num 3, pp 243-248, issn 0192-6233, 6 p.Article

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibitionSANTO, L; VALLET, S; CALABRESE, E et al.Oncogene (Basingstoke). 2010, Vol 29, Num 16, pp 2325-2336, issn 0950-9232, 12 p.Article

Genetic cooperation between p21^Cip1 and INK4 inhibitors in cellular senescence and tumor suppressionQUEREDA, V; MARTINALBO, J; DUBUS, P et al.Oncogene (Basingstoke). 2007, Vol 26, Num 55, pp 7665-7674, issn 0950-9232, 10 p.Article

Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2f dependent and serves as a negative feedback loop limiting cytotoxicityMA, Y; CRESS, W. D.Oncogene (Basingstoke). 2007, Vol 26, Num 24, pp 3532-3540, issn 0950-9232, 9 p.Article

Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporterSANCHEZ, Veronica; MAHR, Jeffrey A; ORAZIO, Nicole I et al.Journal of virology. 2007, Vol 81, Num 21, pp 11730-11736, issn 0022-538X, 7 p.Article

Clinical anticancer drug development: targeting the cyclin-dependent kinasesBENSON, C; KAYE, S; WORKMAN, P et al.British journal of cancer. 2005, Vol 92, Num 1, pp 7-12, issn 0007-0920, 6 p.Article

CDK2-dependent phosphorylation of F0X01 as an apoptotic response to DNA damageHAOJIE HUANG; REGAN, Kevin M; ZHENKUN LOU et al.Science (Washington, D.C.). 2006, Vol 314, Num 5797, pp 294-297, issn 0036-8075, 4 p.Article

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaRAJE, N; HIDESHIMA, T; KIZILTEPE, T et al.Leukemia. 2009, Vol 23, Num 5, pp 961-970, issn 0887-6924, 10 p.Article

Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC 12 cellsCHEN, Mei-Chih; HO LIN; HSU, Fu-Ning et al.American journal of physiology. Cell physiology. 2010, Vol 68, Num 2, issn 0363-6143, C516-C527Article

Infrequent epigenetic dysregulation of CIP/KIP family of cyclin-dependent kinase inhibitors in multiple myelomaCHIM, C. S; LIANG, R; FUNG, T. K et al.Leukemia. 2005, Vol 19, Num 12, pp 2352-2355, issn 0887-6924, 4 p.Article

Design, synthesis, and testing of an 6-0-linked series of benzimidazole based inhibitors of CDK5/p25JAIN, Prashi; FLAHERTY, Patrick T; SHUYAN YI et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 1, pp 359-373, issn 0968-0896, 15 p.Article

Rapamycin : An anti-cancer immunosuppressant?LAW, Brian K.Critical reviews in oncology/hematology. 2005, Vol 56, Num 1, pp 47-60, issn 1040-8428, 14 p.Article

CDK5 interacts with Slo and affects its surface expression and kinetics through direct phosphorylationBAI, Jun-Ping; SURGUCHEV, Alexei; JOSHI, Powrnima et al.American journal of physiology. Cell physiology. 2012, Vol 71, Num 3, issn 0363-6143, C766-C780Article

p57^Kip2 and p27^Kip1 Cooperate to Maintain Hematopoietic Stem Cell Quiescence through Interactions with Hsc70PENG ZOU; YOSHIHARA, Hiroki; HOSOKAWA, Kentaro et al.Cell stem cell. 2011, Vol 9, Num 3, pp 247-261, issn 1934-5909, 15 p.Article

Role of cyclin-dependent kinase 5 in capsaicin-induced coughKAMEI, Junzo; HAYASHI, Shun-Suke; TAKAHASHI, Yoshiki et al.European journal of pharmacology. 2007, Vol 566, Num 1-3, pp 181-184, issn 0014-2999, 4 p.Article

CYCLIN-DEPENDENT KINASE 5-DEPENDENT PHOSPHORYLATION OF PCTAIRE1 REGULATES DENDRITE DEVELOPMENTFU, W.-Y; CHENG, K; FU, A. K. Y et al.Neuroscience. 2011, Vol 180, pp 353-359, issn 0306-4522, 7 p.Article

CRL2^LRR-1 Targets a CDK Inhibitor for Cell Cycle Control in C. elegans and Actin-Based Motility Regulation in Human CellsSTAROSTINA, Natalia G; SIMPLICIANO, Jennifer M; MCGUIRK, Michael A et al.Developmental cell. 2010, Vol 19, Num 5, pp 753-764, issn 1534-5807, 12 p.Article

Cyclin-dependent kinase Inhibitors Inspired by Roscovitine: Purine BioisosteresJORDA, Radek; PARUCH, Kamil; KRYSTOF, Vladimir et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 20, pp 2974-2980, issn 1381-6128, 7 p.Article

Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle moleculesKURIYAMA, Shigeki; HITOMI, Misuzu; MASAKI, Tsutomu et al.International journal of oncology. 2005, Vol 27, Num 2, pp 505-511, issn 1019-6439, 7 p.Article

Preclinical in vitro and in vivo evaluation of the potent and specific cyclin-dependent kinase 2 inhibitor NU6102 and a water soluble prodrug NU6301THOMAS, Huw D; WANG, Lan-Zhen; ROCHE, Celine et al.European journal of cancer (1990). 2011, Vol 47, Num 13, pp 2052-2059, issn 0959-8049, 8 p.Article

Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9BERBERICH, Nina; UHL, Bernd; JOORE, Jos et al.British journal of pharmacology. 2011, Vol 163, Num 5, pp 1086-1098, issn 0007-1188, 13 p.Article